复方雪参胶囊治疗慢性无菌性前列腺炎的临床观察.pdfVIP

西墨 杂志2008年1履蔓37誊第1期 Shanxi Med J，January 2008，Vo1．37，No．1 · 15· 复方雪参胶囊治疗慢性无菌性前列腺炎的临床观察 帼人民解放军总 853 萎 盖 釜 朱捷孙圣坤 【摘 要】 目的 观察复方雪参胶囊治疗慢性非细菌性前列腺炎(G )的临床疗效。方法 将符合试验 标准的130例，分成A组(75例)和B组(55例)，再依据两组前列腺液中的白细胞含量进一步分为：A1组(41 例)、A2组(34例)及B1组(24例)、I32组(31例)。A组服用复方雪参胶囊每次0．75 g，3次／d，B组服用前列康 片，每次3粒，3次／d，共30 d。根据服药前后的各项观察指标的变化情况，进行疗效评定。结果 A组及B组治 疗前后病情比较，差异均有统计学意义(P0．05)，且A组治疗后的病情改善情况及总的疗效与B组比较，差异 亦有统计学意义(P0．05)，但两药对A组Ⅲ级与B组Ⅲ级的疗效差异无统计学意义(P0．05)。结论 口服 复方雪参胶囊及前列康均是CAP的有效治疗方法，复方雪参胶囊的疗效优于前列康，其对炎症性CAP与非炎症 性CAP的疗效差异无统计学意义。 【关键词】前列腺炎；药物疗法；慢性病；复方雪参胶囊； Clinical efficacy of Fufangxueshen capsule in the treatment of chronic abacterial prostatitis 4 Ru．REN H yang，GUO Gang，M 0 7Mlg-li，ZHUfie，SUN Shen—kun． PLA General Hospital，BeTjing 100853，China 【Abstract】Objective To evaluate the effectiveness of Fufangxueshen Capsule in the treatment of chronic abac— terial prostatitis(CAP)patients．Methods One hundred thirty outpatients with a diagn(xsis standard consistent with NIH CAP were dassified into group A(75 cas )and group B(55 cases)．Two groups were divided further into group A1(41cases)，groupA2(34casc~,)andgroupB1(24cas~)，groupB2(31 cases)accordingtOleukocytecountsinEPS， The efficacy w{Ls evaluated by the varieti~of Chronic Prostatitis Syruptom Index(CPSI)after group A had been treat— ed with Fufangxueshen Capsule and group B with Qianliekang Tablet for a month．Results There were statistically significant differences(P0，05)in group A and group B between the pretreatment and posttreatment and the efficacy in group A showed significant difference(P0．05)compared with group B after one month of treatment as well。but no difference(P0．05)between m A andⅢB．Conclusion Both Fufangxueshen Capsule and Qianliekang Tablet are effective for the treatment of CAt’and the former is superior tO the Iatter．but HI A and Ill